Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Major survey launches to map haemophilia across Asia-Pacific

NCT ID NCT07163260

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This study aims to better understand haemophilia in Asia-Pacific countries by collecting survey data from doctors, patient organizations, and people with haemophilia. It will measure how common the condition is, how many new cases occur, and what the care experience is like. No medications or treatments are provided as part of this research.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Novo Nordisk Investigational Site

    Bangalore, Karnataka, 560 066, India

  • Novo Nordisk Investigational Site

    Kuala Lumpur, 50470, Malaysia

  • Novo Nordisk Investigational Site

    Seoul, South Korea

  • Novo Nordisk Investigational Site

    Bangkok, 10500, Thailand

Conditions

Explore the condition pages connected to this study.